Exxonmobil Investment Management Inc. TX decreased its stake in shares of Cooper Companies Inc (NYSE:COO) by 12.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 7,783 shares of the medical device company’s stock after selling 1,139 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Cooper Companies were worth $1,696,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of COO. Janus Henderson Group PLC increased its holdings in shares of Cooper Companies by 558.5% during the 2nd quarter. Janus Henderson Group PLC now owns 2,175,791 shares of the medical device company’s stock valued at $520,937,000 after acquiring an additional 1,845,368 shares during the last quarter. Koch Industries Inc. acquired a new position in shares of Cooper Companies during the 2nd quarter valued at about $312,000. Voya Investment Management LLC increased its holdings in shares of Cooper Companies by 973.4% during the 2nd quarter. Voya Investment Management LLC now owns 329,015 shares of the medical device company’s stock valued at $78,773,000 after acquiring an additional 298,363 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of Cooper Companies by 471.0% during the 3rd quarter. American Century Companies Inc. now owns 316,233 shares of the medical device company’s stock valued at $74,982,000 after acquiring an additional 260,847 shares during the last quarter. Finally, Westfield Capital Management Co. LP increased its holdings in shares of Cooper Companies by 47.8% during the 3rd quarter. Westfield Capital Management Co. LP now owns 636,882 shares of the medical device company’s stock valued at $151,011,000 after acquiring an additional 206,003 shares during the last quarter. 96.73% of the stock is currently owned by institutional investors and hedge funds.

Shares of Cooper Companies Inc (COO) opened at $230.96 on Wednesday. The stock has a market capitalization of $11,280.00, a P/E ratio of 30.71, a price-to-earnings-growth ratio of 1.87 and a beta of 0.54. The company has a quick ratio of 1.26, a current ratio of 2.41 and a debt-to-equity ratio of 0.36. Cooper Companies Inc has a fifty-two week low of $177.69 and a fifty-two week high of $256.39.

Cooper Companies (NYSE:COO) last released its earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.64 by $0.01. The firm had revenue of $561.50 million for the quarter, compared to analyst estimates of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The company’s revenue was up 8.3% on a year-over-year basis. During the same quarter last year, the firm posted $2.28 EPS. equities research analysts forecast that Cooper Companies Inc will post 11.51 earnings per share for the current fiscal year.

The company also recently disclosed a semiannual dividend, which will be paid on Friday, February 9th. Shareholders of record on Tuesday, January 23rd will be given a $0.03 dividend. The ex-dividend date of this dividend is Monday, January 22nd. This represents a dividend yield of 0.03%. Cooper Companies’s dividend payout ratio is currently 0.80%.

In other Cooper Companies news, Director Allan E. Rubenstein sold 6,450 shares of the firm’s stock in a transaction that occurred on Friday, January 12th. The stock was sold at an average price of $228.79, for a total value of $1,475,695.50. Following the completion of the sale, the director now owns 8,628 shares in the company, valued at approximately $1,974,000.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Allan E. Rubenstein sold 500 shares of the firm’s stock in a transaction that occurred on Wednesday, December 27th. The stock was sold at an average price of $222.00, for a total value of $111,000.00. Following the completion of the sale, the director now owns 6,590 shares of the company’s stock, valued at approximately $1,462,980. The disclosure for this sale can be found here. Insiders sold a total of 54,385 shares of company stock valued at $12,289,463 in the last quarter. Corporate insiders own 1.60% of the company’s stock.

A number of research analysts have recently commented on the company. Zacks Investment Research lowered Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. Oppenheimer set a $250.00 target price on Cooper Companies and gave the company a “hold” rating in a report on Friday, December 8th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $265.00 target price (down previously from $275.00) on shares of Cooper Companies in a report on Friday, December 8th. BMO Capital Markets reaffirmed a “buy” rating and issued a $272.00 target price on shares of Cooper Companies in a report on Friday, October 13th. Finally, Robert W. Baird set a $273.00 target price on Cooper Companies and gave the company a “buy” rating in a report on Monday, October 16th. Seven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $259.70.

ILLEGAL ACTIVITY NOTICE: “Exxonmobil Investment Management Inc. TX Has $1.70 Million Stake in Cooper Companies Inc (COO)” was posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international trademark and copyright law. The original version of this piece of content can be read at https://www.dailypolitical.com/2018/01/17/exxonmobil-investment-management-inc-tx-has-1-70-million-stake-in-cooper-companies-inc-coo.html.

Cooper Companies Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.